ID   hAQC2
AC   CVCL_5A34
SY   AQ.C2 clone 100A
DR   Wikidata; Q54881309
RX   Patent=US7358054;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3275.
CC   Characteristics: Produces a humanized version of mAB mAQC2 (Patent=US7358054).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
RX   Patent=US7358054;
RA   Lyne P.D., Garber E.A., Saldanha J.W., Karpusas M.;
RT   "Antibodies to VLA-1.";
RL   Patent number US7358054, 15-Apr-2008.
//